Citadel Advisors’s Benessere Capital Acquisition Corp. Class A Common Stock BENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-69,000
Closed -$716K 15997
2022
Q3
$716K Sell
69,000
-206,000
-75% -$2.13M ﹤0.01% 7710
2022
Q2
$2.84M Buy
275,000
+20,600
+8% +$212K ﹤0.01% 4854
2022
Q1
$2.61M Buy
254,400
+70,000
+38% +$714K ﹤0.01% 5492
2021
Q4
$1.87M Buy
+184,400
New +$1.91M ﹤0.01% 6411

Citadel Advisors's BENE Position: Q1 2022 in Review

Citadel Advisors sold out of Benessere Capital Acquisition Corp. Class A Common Stock (BENE) in Q1 2022, closing a stake of 687,485 shares — an estimated $7.02M sold.

Citadel Advisors first reported a position in BENE in Q4 2021 and held it in 1 quarter. The position peaked at $6.97M in Q4 2021. 36 funds tracked by Wall St. Rank hold BENE as of Q1 2022.

  • Citadel Advisors reported no remaining Benessere Capital Acquisition Corp. Class A Common Stock position as of Q1 2022 after selling out during the quarter.
  • Citadel Advisors sold 687,485 Benessere Capital Acquisition Corp. Class A Common Stock shares in Q1 2022, an estimated $7.02M.
  • Citadel Advisors first reported a position in Benessere Capital Acquisition Corp. Class A Common Stock in Q4 2021 and held it in 1 quarter.
  • Citadel Advisors's Benessere Capital Acquisition Corp. Class A Common Stock position peaked at $6.97M in Q4 2021.
  • 36 funds tracked by Wall St. Rank held Benessere Capital Acquisition Corp. Class A Common Stock as of Q1 2022.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.